LAURA REDENIUS: Open Payments
NPI 1558119784 · BOURBONNAIS, IL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,158 in 57 payments from 15 companies in 2025. Trend: 2023 $0 · 2024 $296 · 2025 $1,158
Food & beverage: $1,158
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 8 | $164 |
| Lilly USA, LLC | 9 | $156 |
| ABBVIE INC. | 5 | $125 |
| AstraZeneca Pharmaceuticals LP | 6 | $118 |
| Radius Health, Inc. | 5 | $117 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 5 | $102 |
| GlaxoSmithKline, LLC. | 4 | $78 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 3 | $55 |
| Exact Sciences Corporation | 3 | $54 |
| Amgen Inc. | 3 | $54 |
Products named: JARDIANCE, Wegovy, VRAYLAR, Tymlos, MOUNJARO, TRELEGY ELLIPTA, XIFAXAN, Cologuard Collection Kit.
Industry payments across IL — which companies pay providers there.
